Open Orphan plc (LON:ORPH), a rapidly growing specialist pharmaceutical services clinical research organisation (CRO) and a world leader in vaccine and antiviral testing using human challenge clinical trials, has announced that the following documents have been sent to shareholders:
· Annual Report and Accounts for the year ended 31 December 2020 (“2020 Annual Report”)
· Notice of Annual General Meeting (“AGM”) 2021 and voting proxy form
In accordance with AIM Rule 26, these documents are also available to view on the Company’s website:
https://www.openorphan.com/investors/reports-and-presentations/year/2021.
The Open Orphan 2020 Annual Report, and the Notice of AGM, which includes details of voting by proxy, have been posted to shareholders who have not consented to receive electronic communications.
The AGM is scheduled to be held at 12 noon BST on 21 July 2021 at the offices of Arden Partners plc, 125 Old Broad St, London EC2N 1AR, and will consider the resolutions set out in the Notice of AGM.
In light of the UK Government’s response to the ongoing COVID-19 outbreak, the Company and the Executive Chairman have determined that the Resolutions to be proposed at the AGM shall be voted on through a poll rather than on a show of hands; and, accordingly, shareholders are strongly encouraged to either submit their Form of Proxy or use the CREST Proxy Voting Service, rather than attend the meeting in person.
